Findings might help reduce organ waiting list, researchers say
April 2016 (HealthDay News)
Hepatitis C virus (HCV)-infected livers seem to do as well as healthy livers in patients with HCV, according to a study presented at the International Liver Congress, held from April 13 to 17 in Barcelona, Spain.
Researchers analyzed data from 33,668 patients with HCV who received a liver transplant in the United States from 1995 to 2013. Of these patients, 5.7 percent received an HCV-positive liver.
The team found there was no difference in time to death between those who received either a liver with hepatitis or a healthy liver. The findings suggest that using HCV-positive livers could help reduce wait times for people with HCV who need a transplant, the researchers said.
“Over the past two decades, mainly due to shortages in organs, the use of HCV-positive organs for liver transplantation has tripled,” study author Zobair Younossi, M.D., chair of the department of medicine at Inova Fairfax Hospital in Falls Church, Va., said in a Congress news release. “Our study clearly shows that people with HCV who received HCV-positive livers had the same medium- to long-term outcomes as people who received healthy livers. As highly effective treatments for HCV are available for transplanted patients, the future of these patients is bright.”
Press Release
More Information
Copyright © 2016 HealthDay. All rights reserved.